SavedAdd your journal

Journals / European Journal of Biology / 2022 / Cilt: 81 - Sayı: 2

Personalized Medicine: A Solution for Today and Tomorrow

Başak DALBAYRAK
Mustafa Doğukan METİNER
Pages
267–273
Publication Date
2022-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increasing demand for personalized medicine affects the improvement scope of this technology; personalized medicine is a vital and urgent area to improve.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Personalized medicine is a multidisciplinary area that contains several techniques to provide patients with more efficient, cheaper, and fewer side effects treatment strategies.
📊
Key Findings & Data:Using liquid biopsy, pharmacogenetics, point-of-care-testing, multi-omicbased technologies, wearable technologies, organoids, and 3D printers are some of the strategies covered in this review.
💡
Conclusion & Impact:Increasing demand for personalized medicine affects the improvement scope of this technology; personalized medicine is a vital and urgent area to improve.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Personalized medicine · Liquid biopsy · Point-of-care-testing

Abstract

Personalized medicine is a multidisciplinary area that contains several techniques to provide patients with more efficient, cheaper, and fewer side effects treatment strategies. In customized medicine, each patient is viewed individually in order to provide more specific and efficient treatment. Using liquid biopsy, pharmacogenetics, point-of-care-testing, multi-omicbased technologies, wearable technologies, organoids, and 3D printers are some of the strategies covered in this review. Omics technology is promising for data collection, and management is vital for health records to combine complete information in one single platform. 3D printer technologies give opportunities to produce multi-drug tablets with controlled and targeted drug release. Additionally, organoids are the other biomaterial approaches to mimic the tumoroid microenvironment to develop new treatment strategies. Increasing demand for personalized medicine affects the improvement scope of this technology; personalized medicine is a vital and urgent area to improve.

🔖

Cite This Article

DALBAYRAK, B., METİNER, M. D. (2022). Personalized Medicine: A Solution for Today and Tomorrow. European Journal of Biology, Cilt: 81 - Sayı: 2, 267–273. https://ajindex.com/articles/876148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Aguado BA, Grim JC, Rosales AM, Watson-Capps JJ, Anseth KS. Engineering precision biomaterials for personalized medicine. Sci Transl Med 2018
  2. 10(424). google scholar 2. Franssen FME, Alter P, Bar N, Benedikter BJ, Iurato S, Maier D, et al. Personalized medicine for patients with COPD: Where are we? Int J COPD 2019
  3. google scholar 3. Gilazieva Z, Ponomarev A, Rutland C, Rizvanov A, Solovyeva V. Promising applications of tumor spheroids and organoids for per-sonalized medicine. Cancers (Basel) 2020
  4. 12(10):1- 19. google scholar 4. Fröhlich H, Balling R, Beerenwinkel N, Kohlbacher O, Kumar S, Len-gauer T, et al. From hype to reality: Data science enabling person-alized medicine. BMC Med 2018
  5. 16(1):1-15. google scholar 5. Mathur S, Sutton J. Personalized medicine could transform health-care (Review). Biomed Reports 2017
  6. 7(1):3-5. google scholar 6. Vogenberg FR, Barash CI, Pursel M. Personalized medicine - Part 1: Evolution and development into theranostics. P T. 2010
  7. 35(10). google scholar 7. Papassotiropoulos A. The potential and limits of personalized medicine. 2012
  8. google scholar 8. Dall’Era MA, Davies BJ, Eggener S. Active surveillance for prostate cancer. Transl Androl Urol 2018
  9. 7(2):195-6. google scholar 9. Sadee W, Dai Z. Pharmacogenetics/genomics and personalized medicine. Hum Mol Genet 2005
  10. 14(2):207-14. google scholar 10. Arciniegas Paspuel, O. G., Âlvarez Hernandez, S. R., Castro Morales, L. G., & Maldonado Gudino CW. Europe Precision Medicine Market. Graphical Research. 2021. p. 6. google scholar 11. Goetz LH, Schork NJ. Personalized medicine: motivation, challeng-es, and progress. Fertil Steril 2018
  11. 109(6):952-63. google scholar 12. Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, et al. Circulating tumor DNA analysis in patients with cancer: Ameri-can society of clinical oncology and college of American patholo-gists joint review. J Clin Oncol 2018
  12. 36(16):1631-41. google scholar 13. Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clin-ic — implementation issues and future challenges. Nat Rev Clin Oncol 2021
  13. 18(5):297-312. google scholar 14. Marrugo-Rarnurez J, Mir M, Samitier J. Blood-based cancer bio-markers in liquid biopsy: A promising non-invasive alternative to tissue biopsy. Int J Mol Sci 2018
  14. 19(10):1-21. google scholar 15. Hardingham JE. Detection of circulating tumor cells using lmmu-nobead-PCR. Clin Appl PCR 2003
  15. google scholar 16. Bidard FC, Fehm T, Ignatiadis M, Smerage JB, Al